Impact of ventricular assist device placement on longitudinal renal function in children with end-stage heart failure

被引:19
|
作者
May, Lindsay J. [1 ]
Montez-Rath, Maria E. [2 ]
Yeh, Justin [3 ]
Axelrod, David M. [4 ]
Chen, Sharon [4 ]
Maeda, Katsuhide [5 ]
Almond, Christopher S. D. [4 ]
Rosenthal, David N. [4 ]
Hollander, Seth A. [4 ]
Sutherland, Scott M. [6 ]
机构
[1] Univ Utah, Sch Med, Dept Pediat, Div Pediat Cardiol, Salt Lake City, UT USA
[2] Stanford Univ, Sch Med, Dept Med, Div Nephrol, Palo Alto, CA 94304 USA
[3] Univ Calif San Diego, Dept Pediat, Div Pediat Cardiol, La Jolla, CA 92093 USA
[4] Stanford Univ, Sch Med, Dept Pediat, Div Pediat Cardiol, Palo Alto, CA 94304 USA
[5] Stanford Univ, Dept Cardiothorac Surg, Div Pediat Cardiac Surg, Palo Alto, CA 94304 USA
[6] Stanford Univ, Sch Med, Dept Pediat, Div Pediat Nephrol, Palo Alto, CA 94304 USA
来源
关键词
ventricular assist device; end-organ dysfunction; renal function; children; end-stage heart failure; ACUTE KIDNEY INJURY; MECHANICAL CIRCULATORY SUPPORT; GLOMERULAR-FILTRATION-RATE; CONTINUOUS-FLOW; CARDIAC-SURGERY; CARDIORENAL SYNDROME; OUTCOMES; TRANSPLANTATION; IMPLANTATION; RISK;
D O I
10.1016/j.healun.2015.10.039
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Although ventricular assist devices (VADs) restore hemodynamics in those with heart failure, reversibility of end-organ dysfunction with VAD support is not well characterized. Renal function often improves in adults after VAD placement, but this has not been comprehensively explored in children. METHODS: Sixty-three children on VAD support were studied. Acute kidney injury (AKI) was defined by Kidney Disease: Improving Global Outcomes criteria. Estimated glomerular filtration rate (eGFR) was determined by the Schwartz method. Generalized linear mixed-effects models compared the pre-VAD and post-VAD eGFR for the cohort and sub-groups with and without pre-VAD renal dysfunction (pre-VAD eGFR < 90 ml/min/1.73 m(2)). RESULTS: The pre-VAD eGFR across the cohort was 84.0 ml/min/1.73 m(2) (interquartile range [IQR] 62.3-122.7), and 55.6% (34 of 63) had pre-VAD renal dysfunction. AKI affected 60.3% (38 of 63), with similar rates in those with and without pre-existing renal dysfunction. Within the cohort, the nadir eGFR occurred 1 day post-operatively (62.9 ml/min/1.73 m(2); IQR, 51.2-88.9 ml/min/1.73 m(2); p < 0.001). By Day 5, however, the eGFR exceeded the baseline (99.0 ml/min/1.73 m(2); IQR, 59.3-146.7 ml/min/1.73 m(2); p = 0.03) and remained significantly higher through the first post-operative week. After adjusting for age, gender, and AKI, the eGFR continued to increase throughout the entire 180-day study period (beta = 0.0025; 95% confidence interval, 0.0015-0.0036; p < 0.001). Patients with pre-VAD renal dysfunction experienced the greatest improvement in the eGFR (beta = 0.0051 vs beta = 0.0013, p < 0.001). CONCLUSIONS: Renal dysfunction is prevalent in children with heart failure undergoing VAD placement. Although peri-operative AKI is common, renal function improves substantially in the first post-operative week and for months thereafter. This is particularly pronounced in those with pre-VAD renal impairment, suggesting that VADs may facilitate recovery and maintenance of kidney function in children with advanced heart failure. (C) 2016 International Society for Heart and Lung Transplantation. All rights reserved.
引用
收藏
页码:449 / 456
页数:8
相关论文
共 50 条
  • [21] Psychiatric Comorbidity and Outcomes After Left Ventricular Assist Device Implantation for End-Stage Heart Failure
    Mullan, Clancy
    Caraballo, Cesar
    Ravindra, Neal G.
    Miller, P. Elliott
    McCullough, Megan
    Brown, Kelly
    Aw, Tsung Wai
    Gruen, Jadry
    Clarke, John-Ross D.
    Velazquez, Eric J.
    Geirsson, Arnar
    Mori, Makoto
    Desai, Nihar R.
    Ahmad, Tariq
    [J]. JACC-HEART FAILURE, 2020, 8 (07) : 569 - 577
  • [22] Ventricular Assist Device Implantation for Infant End-Stage Heart Failure - A Single-Center Experience
    Kim, N.
    Shin, Y.
    Park, Y.
    Park, H.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S520 - S520
  • [23] The role of left ventricular assist device therapy for patients with end-stage heart failure - serbian experience
    Nestorovic, E. Emilija
    Milic, N.
    Putnik, S.
    Terzic, D.
    Ristic, M.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 83 - 83
  • [24] TNFα in patients with end-stage heart failure on medical therapy or supported by a left ventricular assist device
    Bruggink, A. H.
    van Oosterhout, M. F. M.
    De Jonge, N.
    Gmelig-Meyling, F. H. J.
    De Weger, R. A.
    [J]. TRANSPLANT IMMUNOLOGY, 2008, 19 (01) : 64 - 68
  • [25] IMPLANTABLE LEFT-VENTRICULAR ASSIST DEVICE - APPROACHING AN ALTERNATIVE FOR END-STAGE HEART-FAILURE
    MCCARTHY, PM
    JAMES, KB
    SAVAGE, RM
    VARGO, R
    KENDALL, K
    HARASAKI, H
    HOBBS, RE
    PASHKOW, FJ
    [J]. CIRCULATION, 1994, 90 (05) : 83 - 86
  • [26] IMPLANTABLE LEFT-VENTRICULAR ASSIST DEVICE - APPROACHING AN ALTERNATIVE FOR END-STAGE HEART-FAILURE
    MCARTHY, PM
    JAMES, K
    SAVAGE, R
    BRAVO, EL
    VARGO, R
    HARASAKI, H
    PASHKOW, F
    [J]. CIRCULATION, 1993, 88 (04) : 286 - 286
  • [27] Metabolomic and Gene Expression Changes in End-Stage Heart Failure are Reversed by Left Ventricular Assist Device
    Gupte, Anisha
    Hamilton, Dale J.
    Cordero-Reyes, Andrea M.
    Youker, Keith A.
    Loebe, Matthias
    Stevens, Robert D.
    Wenner, Brett
    Ilkayeva, Olga
    Taegtmeyer, Heinrich
    Newgard, Christopher B.
    Torre-Amione, Guillermo
    Hsueh, Willa A.
    [J]. CIRCULATION, 2012, 126 (21)
  • [28] LEFT-VENTRICULAR FUNCTION BEFORE AND AFTER INSERTION OF A PULSATILE ASSIST DEVICE IN PATIENTS WITH END-STAGE HEART-FAILURE
    ATHANASOULIS, T
    SEKELA, ME
    NOON, GP
    MAHMARIAN, JJ
    YOUNG, JB
    VERANI, MS
    [J]. CIRCULATION, 1990, 82 (04) : 383 - 383
  • [29] Evaluation of myocardial function in patients with end-stage heart failure during support with the Jarvik 2000 left ventricular assist device
    Ferrari, M
    Kadipasaoglu, KA
    Croitoru, M
    Conger, J
    Myers, T
    Gregoric, I
    Radovancevic, B
    Letsou, GV
    Frazier, OH
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (02): : 226 - 228
  • [30] Insights in the Prothrombotic Changes After Implantation of a Left Ventricular Assist Device in Patients With End-Stage Heart Failure: A Longitudinal Observational Study
    Liesdek, Omayra C. D.
    Urbanus, Rolf T.
    de Maat, Steven
    de Heer, Linda M.
    Ramjankhan, Faiz Z.
    Sebastian, Silvie A. E.
    Huisman, Albert
    de Jonge, Nicolaas
    Vink, Aryan
    Fischer, Kathelijn
    Maas, Coen
    Suyker, Willem J. L.
    Schutgens, Roger E. G.
    [J]. ASAIO JOURNAL, 2023, 69 (05) : 438 - 444